Elizabeth McKee Anderson
Independent DirectorMs. Elizabeth Mckee Anderson, MBA, also known as Liz, is an Independent Non-Executive Director of GSK plc from September 1, 2022. She has been Independent Director at Aro Biotherapeutics Company. Ms. Anderson has been a Director of Insmed Incorporated since November 6, 2018. Ms. Anderson serves as an Independent Director at BioMarin Pharmaceutical Inc. since July 15, 2019. From 2003 to 2014, Ms. Anderson held various positions at Janssen Pharmaceuticals, Inc. Until her retirement from Johnson & Johnson, she served as the Worldwide Vice President (WWVP) and Commercial Leader in the IDV Global Commercial Strategy Organization, leading strategy, global commercialization and market access for Respiratory Infections, HIV, STI and Bacterial Pathogens and championed acquisition and business cases for more than 25 assets. She was also previously a Board member of Bavarian Nordic A/S. She also serves on the Board of Trustees of The Wistar Institute, a leading biomedical research organisation in the US. She has been Member of the Board of trustees of the Bryn Mawr Hospital Foundation and The Wistar Institute. Principal of PureSight Advisory, LLC. In a prior role as the WWVP Vaccines, she Partnered to develop and execute the first Johnson & Johnson Global Vaccines Strategy, played a key role in the acquisition of Crucell and established capabilities in the field of prevention. Ms. Anderson's prior positions at Janssen Pharmaceuticals, Inc. included Worldwide Vice President, Global Strategic Marketing and Market Access, Infectious Diseases and Vaccines (2010 - 2013); Worldwide Vice President, Global Strategic Marketing and Market Access, Vaccines; Worldwide Vice President, Immunology, Global Strategic Marketing (2008 - 2009); Worldwide Vice President, BIO Strategic Marketing (2006 - 2008); Vice President, Global Biologics Strategic Marketing, Centocor (2004 - 2006); and Vice President, Strategic Planning & Market Research, Centocor (2003- 2004). From 1997 to 2002, Ms. Anderson served as Vice President & General Manager at Wyeth Lederle Vaccines. Prior to Wyeth, Ms. Anderson held various roles at Rhone Poulenc Rorer Pharmaceuticals Inc. (1993 - 1997) and the American National Red Cross (1983 - 1993). She served as Senior Vice President and General Manager, North America, Centeon LLC; Vice President and General Manager, North America, Armour Pharmaceutical Company and Vice President, Worldwide Business Operations, Armour Pharmaceutical Company. She served at Mobay Chemical Company (1979 - 1983). Ms. Anderson served on the Board of Directors of Aro Biotherapeutics Company. She has been an Independent Director of Revolution Medicines, Inc. since March 2015. She had been Independent Director of Bavarian Nordic A/S since April 25, 2017 until August 23, 2022. She had been an Independent Non-Executive Director at Huntsworth plc since January 1, 2018 until December 31, 2019. She serves as the Independent Board Director of Context Therapeutics. She serves as a Member of Advisory Board at NAXION, Inc. Ms. Anderson received a B.E. in Engineering and Technical Management from Rutgers, the State University of New Jersey and an M.B.A. in Finance from Loyola University Maryland.
Positions
- Company NameBioMarin Pharmaceutical Inc.Stock CodeBMRNPositionIndependent DirectorColleagues
- AHAlexander HardyPresident, CEO & Director
- ITIan T. ClarkIndependent Chair of the Board
- BRBrian R. MuellerCFO & Executive VP of Finance
- CGC. Greg GuyerExecutive VP & CTO
- CHCristin HubbardExecutive VP & Chief Commercial Officer
- GFGregory FribergExecutive VP and Chief Research & Development Officer
- RJRobert J. HombachIndependent Director
- MJMark Joseph EnyedyIndependent Director
- Company NameRevolution Medicines, Inc.Stock CodeRVMDPositionIndependent DirectorRelated SecuritiesColleagues
- MAMark A. GoldsmithCEO, President & Chairman
- JAJack AndersChief Financial Officer
- MAMargaret A. HornChief Operating Officer
- JCJeffrey CisliniSenior VP, General Counsel & Corporate Secretary
- SMStephen M. KelseySenior Advisor
- MDMartin D. BurkeCo-Founder & Chairman of Scientific Advisory Board
- MAMichael A. FischbachAcademic Co-Founder & Member of Scientific Advisory Board
- KMKevan M. ShokatAcademic Co-Founder & Member of Scientific Advisory Board
- EMElizabeth McKee AndersonIndependent Director
